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Abstract: A review of 23 studies investigating the prevalence of Behavioural and 
psychological symptoms of dementia (BPSD) in the general and learning disability 
population and measures used to assess BPSD was carried out. BPSD are non-cognitive 
symptoms, which constitute as a major component of dementia regardless of its subtype 
Research has indicated that there is a high prevalence of BPSD in the general dementia 
population. There are limited studies, which investigate the prevalence of BPSD within 
individuals who have learning disabilities and dementia. Findings suggest BPSDs are present 
within individuals with learning disabilities and dementia. Future research should use 
updated tools for investigating the prevalence of BPSD within individuals with learning 
disabilities and dementia. 
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1. Introduction 
Dementia is a clinical syndrome, which is characterised by the deterioration of mental functioning. 
This includes the development of various cognitive and intellectual deficits, which can affect the ability 
to carry out everyday tasks [1]. There is no known cure for progressive dementias, however a variety of 
treatments are available to alleviate the associated symptoms [2]. Dementia is a degenerative condition, 
most prominent within older adults. An estimated one million people in the UK will have dementia by 
2025 [3]. Dementia has a costly impact on the economy; currently costing the UK over £26 billion a 
year to cover health and social care costs [3,4]. 
Over time, the general life expectancy of individuals with learning disabilities has steadily increased [5] 
thus leading to dementia becoming a growing issue within this population. Learning disabilities is an 
umbrella term covering a range of difficulties which can interfere with the acquisition and use of 
reasoning, writing and reading skills, as well as other intellectual, social abilities [6]. Previous research 
has indicated that the prevalence of dementia is greater in people with learning disabilities as opposed 
to the general population [7,8]. Research has established that there is an increased risk of early onset 
dementia of the Alzheimer type in people who have Down’s syndrome [9–11]. Findings have suggested 
that one in three people with Down’s syndrome will develop dementia in their 50s, as well as over half 
of those who live to the age of 60 or over [12]. 
A widespread series of behavioural and psychological symptoms are common in dementia, some of 
which include apathy, aggression, delusions, psychosis, hallucinations anxiety, irritability, eating 
disturbances and sleep disorders [13]. Behavioural and psychological symptoms of dementia (BPSD) 
are non-cognitive symptoms, which constitute as a major component of dementia regardless of its 
subtype [3]. BPSD often occur in clusters such as hyperactivity, including agitation and aggression, 
affective symptoms including depression and anxiety, and psychosis, including both delusions and 
hallucinations [13]. The prevalence of specific symptoms vary between study to study. In general, 
hallucinations have been reported in 15%–49% of patients with dementia, delusions have been found in 
10%–73% of dementia patients. Affective symptoms such as depression are less common; however, this 
could be due to the difficulty in differentiating between symptoms of depression and dementia as they 
can both co-occur. Incidences of behavioural disturbances such as agitation and aggression have been 
found to be highly prevalent within people who have dementia, with studies reporting a mean prevalence 
of 46.2% [14]. 
Behavioural and psychological symptoms cause considerable distress to both the patient and carer, 
and could potentially reduce their quality of life [15]. Furthermore, research has indicated that BPSD 
can be significant predictors of institutionalisation [16,17]. The nature of BPSD is not fully understood; 
therefore the treatment options are minimal. Pharmacological treatments alleviate specific symptoms, 
examples of which include the use anti-dementia drugs such as Memantine and antipsychotics such as 
Olanzapine and Risperidone [18]. The use and efficacy of non-pharmacological interventions, such as 
Snoezelen (multi-sensory stimulation), have also been investigated throughout research [19]. 
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The purpose of this literature review is to provide a critical evaluation the methodology of research 
exploring the prevalence of BPSD within individuals who have to learning disabilities and dementia. 
2. Literature Search 
There is no global definition of BPSD. The behavioural and psychological symptoms of dementia 
were previous recognised as neuropsychiatric, maladaptive or non-cognitive behavioural disturbances [20]. 
For the purposes of this literature review the following definition of BPSD was used “Signs and 
symptoms of disturbed perception, thought content, mood, or behaviour that frequently occur in patients 
with dementia” [21]. The literature search was carried out using the search engines such as Google 
scholar and databases, such as PubMed, Wiley, Science Direct, Cambridge journals, and Psych Articles. 
Combinations of key search terms and phrases used are shown below. 
Terms: 
 BPSD 
 Learning disabilities 
 Dementia 
 BPSD Prevalence 
 Neuropsychiatric inventory 
 Psychiatric symptoms 
 Neuropsychiatric symptoms 
 Non cognitive symptoms 
 Mood changes 
 Maladaptive behaviours 
 Behavioural disturbances 
 Psychological changes 
Inclusion and Exclusion Criteria 
Inclusion and exclusion criteria aid in selecting relevant studies. Research articles that focused on the 
non-cognitive symptoms of dementia in learning disabilities were included. Studies that did not focus 
on the aims of this literature review, such as articles based on treatment of BPSD, were excluded for the 
purposes of this literature review. Furthermore, when searching for BPSD in the general population, 
articles, which had population samples under 60, were excluded, as prevalence rates would be difficult 
to compare to other studies with larger sample sizes. 
3. Prevalence of BPSD in the General Population 
Behavioural and psychological symptoms of dementia (BPSD) effect up to 90% of those diagnosed 
with dementia at any given point in the duration of their illness [3]. There have been various studies that 
have investigated the prevalence of BPSD within the general population (see Table 1).  
Savva et al. [22] conducted a longitudinal population based study over a period of 10 years. BPSD 
prevalence was assessed in people with and without dementia. The results suggested that each BPSD 
excluding sleep disturbance was significantly higher in people with dementia compared to those without 
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dementia. Haupt, Kurz and Jenner [23], reported similar findings within their two year study, stating that 
all participants experienced at least one BPSD within the duration of the study. There are major flaws, 
which weaken the overall findings of longitudinal studies. Sample sizes are difficult to maintain in 
longitudinal studies. Savva et al. [22], reported that a total of 587 participants who had dementia and 
2050 that did not have dementia were used for the baseline assessment. However, only 244 participants 
were reassessed after 22 months (42%). 
Table 1. Studies investigating behavioural and psychological symptoms of dementia 
(BPSD) in the general population. 
Author,  
Year, Country 
Aim 
Measure Used to  
Assess Behavioural and 
Psychological Symptoms of 
Dementia (BPSD) 
Participants 
(n) 
Main Findings 
Savva et al. [22], UK 
To describe the prevalence,  
correlates and course of BPSD  
in the population of England  
and Wales 
Cambridge Mental Disorders 
of the Elderly Examination  
CAMDEX Geriatric Mental  
State (GMS) interview 
587 
Prevalence in dementia participants 
was significantly higher than  
non-dementia group apathy was  
highest (50.3%) followed  
by irritability (28.8) 
Chiu, Chen,  
Yip, Hau and Tang  
[24], Taiwan 
Prevalence of BPSD in  
patients with four major  
types of dementia  
Behavioural Pathology in  
Alzheimer’s Disease  
Rating Scale (BEHAVE-AD) 
137 
BPSD were found in 92.0%  
of the patients 
Margallo-Lana et al.,  
[25], UK 
To determine the prevalence of  
BPSD in care environments,  
their relationship with severity  
of dementia and the pattern of  
psychotropic medication 
Neuropsychiatric  
inventory (NPI) 
231 
79% of participants had  
clinically significant BPSD 
Ballard et al.,  
[26], UK 
Examining the prevalence,  
incidence, and outcome of  
the 3 main BPSD (agitation,  
depression, and psychosis)  
in care facilities 
Neuropsychiatric  
inventory (NPI) 
136 
Prevalence of BPSD was 76% at  
baseline and 82% at follow-up 
Brodaty et al.,  
[27], Australia 
To investigate the prevalence of  
BPSD in nursing home residents  
using the BEHAVE-AD 
BEHAVE-AD  
(Behavioural Pathology  
in Alzheimer’s Disease) 
647 
Over 90% of participants  
rated positive for BPSD 
Habio et al.,  
[28], China 
Study of the prevalence of  
BPSD in population based  
community-living persons  
with dementia  
NPI (Neuropsychiatric  
inventory) 
1271 50.1% had at least one BPSD 
Haupt, Kurz and 
Janner  
[23], Germany 
Examine the longitudinal  
occurrence and persistence of  
BPSD in Alzheimer’s disease 
Behavioural Abnormalities  
in AD Rating scale  
(BEHAVE-AD) 
60 
100% of participants experienced  
BPSD over 2 year period 
The overall reliability of the findings would be questionable as less than half the participants provided 
a second interview, thus comparisons made with overall baseline measure would not be completely valid 
unless their data was excluded. Furthermore, the participant groups were far from balanced, the prevalence 
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of BPSD was compared between 587 participants with dementia and 2050 without dementia. However, 
the general results from the study-mirrored findings from other longitudinal studies (Chache Country 
study and Nakayama study) so in this case the imbalance was not a significant issue. 
The use of smaller sample sizes could increase the validity and reliability of longitudinal studies, 
Haupt, Kurz and Jenner [23] used a sample of 60 dementia participants to investigate the prevalence of 
BPSD, all of which were available for follow up BPSD assessments over a two-year period. A final issue 
with the use of longitudinal studies is the inability to record constant observations. Both  
Savva et al. [22] and Haupt, Kurz and Jenner [23] were not able to observe any short-term fluctuations 
or short episodes of symptoms. 
BPSD prevalence rates of 79% and above were reported in the five of the eight studies [23–28]. This 
indicates a consistency of reliable results across all five studies; however, a variety of measures were 
used to assess BPSD. One measure used to assess BPSD is the behavioural pathology in Alzheimer’s 
disease (BEHAVE-AD). BEHAVE-AD is a well-known, valid measure of BPSD, which consists of a 
set of questions given to an informant during an interview with a clinician. Chiu, Chen, Yip, Hau and 
Tang [24] Brodaty et al. [27] and Haupt, Kurz and Janner [23] used BEHAVE-AD as the main form of 
BPSD assessment. Their results were found be highly consistent with each other, all reporting a BPSD 
prevalence at 90% or over (see Table 1). Therefore, indicating the use of BEHAVE-AD to assess BPSD as 
a valid measure. The remaining studies [25,26,28] (see Table 1) used the Neuropsychiatric inventory 
(NPI) also reported similar findings between each other. 
In conclusion, research has indicated that there is a high prevalence of BPSD in the general dementia 
population. The studies used to investigate the prevalence of BPSD in the general population reported 
consistent findings. The use of different measures to assess BPSD did not affect the overall reliability of 
the results, as both the NPI and BEHAVE-AD are highly valid tools used to assess BPSD in multiple 
studies. The population samples used in the studies were of a significant size, thus further increasing the 
reliability and ecological validity of the general findings. 
4. Prevalence of BPSD in the Learning Disability Population 
There are limited studies that investigate the prevalence of BPSD within individuals who have 
learning disabilities and dementia. Due to the lack of research, it is difficult to provide a general 
consensus regarding the prevalence of BPSD within this specific population sample. During the initial 
literature search, “BPSD in learning disabilities and dementia” yielded no valid results in any database. 
However using a combination of other terms (see Section 2) eight appropriate studies were selected  
(see Table 2). 
The studies do not investigate the prevalence of BPSD as a whole in the learning disability population. 
Each study focuses either on the behavioural or psychiatric symptoms of dementia. Aggressive behaviour 
is a common problematic behavioural symptom of dementia [29]. Duggan, Lewis and Morgan [30] and 
Cooper and Prasher [31] reported a high prevalence of aggressive behaviour within individuals with 
learning disabilities and dementia. Apathy and depression are both behavioural problems prevalent in 
dementia. Depression has been described in 0%–87% of dementia patients. Approximately 80% of 
Alzheimer’s disease patients are apathetic during the progression of their illness [32]. Depression and 
apathy have also been reported in studies examining participants with learning disability and dementia. 
Diagnostics 2015, 5 569 
 
 
Burt, Loveland and Lewis [33] suggested that depression and dementia were associated in people who 
have Down’s syndrome. 
Table 2. Studies investigating behavioural and/or psychiatric symptoms within individuals 
with learning disabilities and dementia. 
Author,  
Year, Country  
Aim Measure 
Participants 
(n) 
Main Findings 
Duggan, Lewis  
and Morgan [30], UK  
Investigating behavioural  
changes in individuals  
with learning disability  
and dementia 
Past Behaviour  
Health Inventory (PBHI) 
12 
Reported aggression,  
sleep and eating disturbances  
in participants 
Prasher and Filer [35], UK 
Investigating behavioural  
disturbances in people  
with downs syndrome  
and dementia 
Full access to article  
was unavailable 
45 
Reported findings of low mood,  
sleep disturbance and wandering  
in participants with dementia  
and downs syndrome 
Cooper and Prasher [31], 
UK 
Compared the occurrence of  
maladaptive behaviours in  
individuals with dementia with 
and without downs syndrome 
Present Psychiatric State  
Learning Disability Scale  
(PPSD) 
134 
Reported high prevalence of  
aggressive behaviour (61.5%) 
Cooper [7], UK 
Determine the rate of 
psychiatric  
symptoms amongst the elderly  
with learning disabilities  
and dementia 
Present Psychiatric State  
Learning Disability Scale  
(PPSD) 
143 
Psychiatric symptoms  
reported in 27.6% participants 
Moss and Patel [37], UK 
Psychiatric symptoms 
associated  
with dementia in older people  
with learning disability 
Psychiatric Assessment  
Schedule for Adults with  
a Developmental 
Disability  
(PAS-ADD) 
105 
Participants with definite dementia  
had higher levels of sleep difficulty,  
hypersomnia, irritability, inefficient  
thought, loss of interest and 
anhedonia 
Burt, Loveland  
and Lewis [33], USA 
Examined the relation between 
dementia and depression in  
61 adults with Down and  
43 adults with mental 
retardation 
Neuropsychological  
battery to assess declines  
in functioning 
104 
Results suggest that dementia  
and depression were associated  
in downs syndrome 
Prasher [35], UK 
Investigated age-specific  
prevalence, thyroid dysfunction 
and depressive 
symptomatology  
in adults with Down syndrome 
and dementia 
Full access to article  
was unavailable 
201 
Depressive symptomatology of  
depressed mood, weight loss and  
reduced appetite were associated  
with dementia in adults with  
downs syndrome 
Moss and Patel [36], UK 
Investigated symptoms of  
physical and mental illness  
and levels of adaptive 
behaviour  
in adult with dementia and  
intellectual disabilities 
Psychiatric Assessment  
Schedule for Adults with  
a Developmental 
Disability  
(PAS-ADD) 
101 
Reported sleep difficulty, 
hypersomnia  
and irritability as significantly severe 
in adults with dementia and  
intellectual disability 
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Prasher and Filer [34] provide further support for these results, reporting findings of low mood in  
134 participants who had Down’s syndrome and dementia. Prasher [35] replicated findings in a larger 
study using 201 participants and described depressive symptomology in adults with Down’s syndrome  
and dementia. 
Over half the studies (62.5%) selected (see Table 2) state a high prevalence of sleep disturbances 
within people with learning disabilities and dementia. Savva et al. [22] mirrored these results in patients 
with dementia without learning disabilities. Cooper [7] investigated psychiatric symptoms in adults with 
learning disabilities and dementia in a population study. The results suggested that 27.6% of participants 
suffered from psychiatric symptoms. Highly prevalent symptoms reported from the studies investigating 
behavioural and or psychiatric symptoms of dementia in adults with learning disabilities (see Table 2) 
have also been reported in the general dementia population (see Table 1). It is evident that behavioural 
and psychological symptoms are present in adults with dementia whether they have a learning disability 
or not. 
A general issue with the studies investigating BPSD relates to the type of measure used for 
assessment. There is no gold-standard instrument to measure BPSD in the learning disability population. 
Dugan, Lewis and Morgan [30] used the past behaviour inventory (PBHI). PBHI is an out-dated  
self-report questionnaire; there are many updated behavioural measures for assessing BPSD, such as the 
neuropsychiatric inventory. The PBHI is limited to reporting behavioural issues and does not account 
for any psychological behaviour. Therefore, the PBHI would not be able to assess any of the psychological 
elements relating to BPSD, Furthermore, the PBHI questionnaire relies completely on self-report, 
patients displaying BPSD may not be able to distinguish between behavioural and psychological 
symptoms. Additionally, patients may also not be aware of presenting any symptoms. The measure is 
also not specified for patients with dementia. Therefore, it can be concluded that the PHBI is a not a 
valid measure for BPSD. 
Additional tools used for assessing BPSD in the learning disability population include the Present 
Psychiatric State Learning disability Scale (PPSD) and Psychiatric Assessment Schedule for Adults with 
Developmental Disabilities (PAS-ADD). Cooper and Prasher [31] and Cooper [7] both used the PPSD 
when investigating maladaptive and psychiatric behaviours in adults with learning disabilities. Moss and 
Patel [36,37] used the updated version, PAS-ADD. Both measures are semi-structured interviews, 
specifically designed for the detection of mental disorders in people with intellectual disabilities. The 
PAS-ADD and the PPSD are not valid measures of assessing BPSD. As they focus solely on the 
psychiatric symptoms and states of participants with learning disabilities. Therefore, both the PAS-ADD 
and PPSD are unable to assess any of the behavioural aspects of BPSD. Detailed behavioural and 
psychological behaviours can be difficult to assess with these scales. Furthermore, neither scale is 
specified for detecting symptoms in patients with dementia. In general, the overall strength of the  
PAS-ADD is that it is suitable to use for the learning disability population. The questions are especially 
developed and adapted for the specific population. The PHBI however, is more of a general behavioural 
measure, which can be administered to anyone in the general population. An additional instrument used 
to assess BPSD is the BEHAVE-AD scale. BEHAVE-AD assess behavioural and psychological elements 
of Alzheimer disease, however due to the specific focus on symptoms associated with Alzheimer’s 
disease the scale may not be generalizable. 
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The PBHI, PAS-ADD and PPSD have various flaws in regards to the assessment of BPSD. None of 
the three scales mentioned assess both the behavioural and psychological symptoms associated with 
dementia. Thus, the scales would not be able to provide an accurate assessment of BPSD in the learning 
disability population. 
To conclude, the measures used in the studies are difficult to validate, thus making methodological 
comparisons challenging. The most evident comparison is between Moss and Patel [36,37] both studies 
reported a high prevalence of sleep difficulty, hypersomnia and irritability with the use of  
PAS-ADD. All eight studies were conducted in the 1990s; BPSD was a relatively new and developing 
term during this period. This may explain the lack of research within the selected population and the use 
of out-dated measures. Future research within this area should use updated tools for investigating the 
prevalence of BPSD within individuals with learning disabilities and dementia. 
5. Use of Neuropsychiatric Inventory (NPI) 
The vast majority of recent studies of have used the Neuropsychiatric Inventory (NPI) to assess  
BPSD (see Table 3). The NPI was developed by Cummings et al. [38]. The NPI is administered by the 
clinician to the caregiver. The caregiver is usually a family member involved in the daily care of  
the patient. The NPI can be administered to a professional caregiver or other involved person as long as 
they have detailed knowledge of the patient’s behaviour. Multiple Studies have demonstrated the content 
and concurrent validity, as well as between-rater, test-retest, and internal consistency reliability of the 
NPI. The NPI is both a valid and reliable measure of BPSD. The NPI has the advantages of evaluating 
a wider range of psychopathology than existing instruments, whilst minimizing administration time [38]. 
There are several versions of the NPI, such as the NPI-Q, NPI-NH and the NPI-C. Some versions have 
also been translated into various languages. 
Studies that have used the NPI to assess BPSD, have reported similar results. The prevalence of BPSD in 
the population has been estimated in various well known longitudinal studies (Nakayama and the Cache 
County study) Each of these studies used NPI and their results are largely [22]. All eight studies have reported 
over a 50% prevalence of BPSD (see Table 3). Frequently-reported BPSD include apathy, aggression, 
agitation and irritability [22,25]. The vast majority of studies (90%) using the NPI to assess BPSD have 
reported these symptoms as highly prevalent. The studies discussed (see Table 3) indicate the clear 
consistency of results gained from using the NPI. An additional strength of the NPI is that it is explicitly for 
the use of investigating the behavioural and psychological domains is common in dementia. This rules out 
other symptoms patients maybe experiencing which are not related to dementia. 
Based on theoretical considerations, the NPI has potential to be a valid tool used to assess BPSD,  
It is explicitly developed for the use of assessing neuropsychiatric symptoms of dementia. The studies 
discussed aid in supporting the use of the NPI for future research. It can be assumed that the NPI can be 
used efficiently to assess the prevalence of BPSD in individuals with learning disabilities. 
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Table 3. Studies using the Neuropsychiatric inventory (NPI) to assess BPSD. 
Author,  
Year, Country  
Aim 
Measure Used  
to Assess Behavioural and 
Psychological Symptoms of 
Dementia (BPSD) 
Participants 
(n) 
Main Findings 
Lyketsos et al. 
[39], USA 
To estimate the prevalence  
of neuropsychiatric 
symptoms in dementia 
NPI 3608 
80% had at least one symptom. The most  
frequent disturbances were apathy (36%),  
depression (32%), and agitation/aggression 
(30%) 
Ikeda et al.  
[40], Japan 
Investigate the prevalence of  
mental behavioural 
disturbances associated with 
dementia in elderly people 
NPI 60 
88.3% had shown one or more mental and 
behavioural disturbances. Common symptoms 
include Apathy (56.7%), agitation/aggression  
(35%), aberrant motor behaviour (31.7%), and 
irritability (31.7%) 
Margallo-Lana 
et al. [25], UK  
To determine the prevalence 
of BPSD in care 
environments, their 
relationship with severity of 
dementia and the pattern of 
psychotropic medication 
NPI 231 
79% of participants had clinically  
significant BPSD. Most common  
symptom was agitation (48%) 
Ballard et al.  
[26], UK 
Examining the prevalence,  
incidence, and outcome of 
the 3 main BPSD (agitation,  
depression, and psychosis)  
in care facilities 
NPI 136 
Prevalence of BPSD was 76% at baseline and 
82% at follow-up. Most common symptom was 
agitation, occurring in 55% of ps 
Habio et al.  
[28], China 
Investigate prevalence of  
BPSD in population based  
community-living persons  
with dementia 
NPI 1271 
50.1% had BPSD. The most common  
symptoms were sleep disturbance (21.9%), 
irritability (19.6%), apathy (15.7%) 
Ballard et al.  
[26], UK 
Investigated the impact of  
BPSD on quality of life  
in people with dementia 
NPI 209 
54% had at least one BPSD. Most common 
symptom was agitation (64%) followed  
by irritability (45%) 
Haung, et al. 
[41], Taiwan  
Investigated impact of  
BPSD on carer burden 
NPI 88 
84.1% had at least one BPSD. Most common  
symptom was dysphoria/depression (40.9%),  
followed by anxiety 37.5% 
Neil and Bowie 
[42], UK 
Investigated impact of  
BPSD on carer burden 
NPI 30 
BPSD present in 96.2% of ps, most common  
included hallucinations (62%) and agitation 
(51%) 
Pilot Study 
A pilot study was conducted to examine the prevalence of BPSD in the learning disability population 
using the neuropsychiatric inventory (NPI-Q). Individuals with learning, disabilities both with and 
without dementia, were recruited via the Leicestershire Frith Hospital. The participant sample contained 
six cases with learning disabilities dementia. The remaining three participants did not have a dementia 
diagnosis, therefore were controls. The results from the pilot study clearly indicated all 12 BPSD were 
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reported more frequently in participants with dementia than without dementia. The most frequent BPSD 
was night-time behaviours, reported in 66.7% of participants with dementia. The least common BPSD 
was depression/dysphoria and eating behaviours, which was only present in 16.7% of participants with 
dementia. Findings suggest a strong prevalence of BPSD in individuals with learning disability and 
dementia. However, further research is required to be able gain a greater understanding of BPSD. 
6. Discussion 
The aim of this literature review was to describe BPSD prevalence in the general and learning 
disability population. It has been estimated that BPSD effects up to 90% of all dementia subjects over 
the progression of their illness [3]. Throughout the majority of dementia diagnostics criteria BPSD have 
not been included as core features of defining dementia. However, two thirds of people with dementia 
experience BPSD at any one point during the course of dementia. Investigations of the prevalence of 
BPSD have produced varied findings across differing settings. The studies used in this literature review 
have indicated that there is a high prevalence of BPSD in the general population. 
It is apparent that there is a gap within research exploring the prevalence of BPSD in individuals with 
learning disabilities. Findings from upcoming research could lead to a greater understanding of BPSD, 
thus aid in possibly creating interventions to make symptoms more manageable. The results indicate that 
individuals with learning disabilities and dementia may also suffer from various psychiatric and 
behavioural disturbances. However, the differing measures used these studies have made methodological 
comparisons extremely difficult. 
The results suggest that the NPI is a valid measurement used to assess BPSD. The NPI covers  
12 major domains of BPSD and is easy to administer. Furthermore, the NPI has been adapted to be 
administered in a variety of settings such as institutional settings and has been translated into various 
languages, which potentially makes it a universal tool used for assessing BPSD. 
The NPI could be a potentially reliable measure of assessing the prevalence of BPSD in the learning 
disability population. It is administered to the carer and is dementia focused, which allows it to rule out 
symptomology from other conditions. 
7. Conclusions 
The overall findings from this literature review imply that BPSD is a highly prevalent issue within 
dementia. BPSD have been found in those with learning disabilities and dementia, however additional 
research with valid measures is required to support these findings. The literature review has indicated 
that further research within this specific area is necessary, especially comparing studies, which use the 
same tools to assess BPSD. Although the present literature review is not exhaustive due to the lack of 
research, it highlights the need for future studies to investigate the prevalence of BPSD within individuals 
with intellectual or learning disabilities. 
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